Literature DB >> 18715410

Cerebral palsy and restricted growth status at birth: population-based case-control study.

B Jacobsson1, K Ahlin, A Francis, G Hagberg, H Hagberg, J Gardosi.   

Abstract

OBJECTIVE: To evaluate the association between growth status at birth and subsequent development of cerebral palsy in preterm and term infants.
DESIGN: Population-based case-controlled study.
SETTING: Cerebral palsy register in Western Sweden. Subjects Cohort of 334 singletons born between 1983 and 1990, with cerebral palsy diagnosed from age 4, and 668 singletons matched for gestation, gender and delivery unit.
METHOD: Growth status at birth was determined using small for gestational age (SGA) categories, with customised birthweight percentiles (SGAcust) based on the Swedish population. MAIN OUTCOME MEASURES: Proportion of babies that were SGAcust, comparing cases and controls in three gestational age categories: early preterm (24-33 weeks), late preterm (34-36 weeks) and term (37+ weeks).
RESULTS: Of the 334 children with cerebral palsy, 87 (26.6%) were born early preterm, 27 (8.1%) late preterm and 218 (66%) at term. Children who had been born at term were more likely to have been SGA <1st customised percentile (SGAcust1) than their matched controls (OR 6.6, 95% CI 2.3-18.6). In contrast, children with cerebral palsy born preterm were not more likely to have been SGAcust1 (OR 0.9, 95% CI 0.4-1.9), and this applied to early preterm as well as late preterm births. For less severely small babies (SGA between 1st and 5th customised percentiles), the association with cerebral palsy remained significant for term births (OR 5.2, 95% CI 2.7-10.1) but was again not significant for preterm births.
CONCLUSIONS: Term singletons with severely SGA birthweights had a five- to seven-fold risk of developing cerebral palsy compared with gestational age-matched infants with birthweights within normal limits. For children born preterm, SGA was not more likely to be present in cases than in controls. These findings support the concept of cerebral palsy as a multifactorial condition and highlight the importance of antenatal surveillance of fetal growth.

Entities:  

Mesh:

Year:  2008        PMID: 18715410     DOI: 10.1111/j.1471-0528.2008.01827.x

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  40 in total

1.  Birth weight- and fetal weight-growth restriction: impact on neurodevelopment.

Authors:  Iris G Streimish; Richard A Ehrenkranz; Elizabeth N Allred; T Michael O'Shea; Karl C K Kuban; Nigel Paneth; Alan Leviton
Journal:  Early Hum Dev       Date:  2012-06-23       Impact factor: 2.079

2.  Murine maternal dietary restriction affects neural Humanin expression and cellular profile.

Authors:  Claire Baldauf; Monica Sondhi; Bo-Chul Shin; Young Eun Ko; Xin Ye; Kuk-Wha Lee; Sherin U Devaskar
Journal:  J Neurosci Res       Date:  2019-12-15       Impact factor: 4.164

3.  The risk of intrauterine fetal death in the small-for-gestational-age fetus.

Authors:  Rachel A Pilliod; Yvonne W Cheng; Jonathan M Snowden; Amy E Doss; Aaron B Caughey
Journal:  Am J Obstet Gynecol       Date:  2012-10       Impact factor: 8.661

4.  Intrauterine Growth Restriction and Hyperoxia as a Cause of White Matter Injury.

Authors:  Jill L Chang; Mirrah Bashir; Christiana Santiago; Kathryn Farrow; Camille Fung; Ashley S Brown; Robert W Dettman; Maria L V Dizon
Journal:  Dev Neurosci       Date:  2018-11-14       Impact factor: 2.984

5.  Customized versus population approach for evaluation of fetal overgrowth.

Authors:  Maged M Costantine; Lisa Mele; Mark B Landon; Catherine Y Spong; Susan M Ramin; Brian Casey; Ronald J Wapner; Michael W Varner; Dwight J Rouse; John M Thorp; Anthony Sciscione; Patrick Catalano; Steve N Caritis; Yoram Sorokin; Alan M Peaceman; Jorge E Tolosa; Garland D Anderson
Journal:  Am J Perinatol       Date:  2012-11-12       Impact factor: 1.862

6.  Population versus customized fetal growth norms and adverse outcomes in an intrapartum cohort.

Authors:  Maged M Costantine; Yinglei Lai; Steven L Bloom; Catherine Y Spong; Michael W Varner; Dwight J Rouse; Susan M Ramin; Steve N Caritis; Alan M Peaceman; Yoram Sorokin; Anthony Sciscione; Brian M Mercer; John M Thorp; Fergal D Malone; Margaret Harper; Jay D Iams
Journal:  Am J Perinatol       Date:  2012-08-14       Impact factor: 1.862

7.  Delayed myelination in an intrauterine growth retardation model is mediated by oxidative stress upregulating bone morphogenetic protein 4.

Authors:  Mary V Reid; Kaitlin A Murray; Eric D Marsh; Jeffrey A Golden; Rebecca A Simmons; Judith B Grinspan
Journal:  J Neuropathol Exp Neurol       Date:  2012-07       Impact factor: 3.685

Review 8.  The genomic basis of cerebral palsy: a HuGE systematic literature review.

Authors:  M E O'Callaghan; A H MacLennan; E A Haan; G Dekker
Journal:  Hum Genet       Date:  2009-02-24       Impact factor: 4.132

9.  Antecedents of neonatal encephalopathy in the Vermont Oxford Network Encephalopathy Registry.

Authors:  Karin B Nelson; Peter Bingham; Erika M Edwards; Jeffrey D Horbar; Michael J Kenny; Terrie Inder; Robert H Pfister; Tonse Raju; Roger F Soll
Journal:  Pediatrics       Date:  2012-10-15       Impact factor: 7.124

10.  Melatonin promotes oligodendroglial maturation of injured white matter in neonatal rats.

Authors:  Paul Olivier; Romain H Fontaine; Gauthier Loron; Juliette Van Steenwinckel; Valérie Biran; Véronique Massonneau; Angela Kaindl; Jeremie Dalous; Christiane Charriaut-Marlangue; Marie-Stéphane Aigrot; Julien Pansiot; Catherine Verney; Pierre Gressens; Olivier Baud
Journal:  PLoS One       Date:  2009-09-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.